<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study recurrence risk after withdrawal of <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs in children with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> children younger than 14 with two or more unprovoked <z:hpo ids='HP_0001250'>seizures</z:hpo> 24h apart who were seen at our Hospital between 1994 and 2004 were included consecutively and prospectively followed </plain></SENT>
<SENT sid="2" pm="."><plain>Patients previously examined in other centres were excluded </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients who entered a remission were proposed to stop medication and were followed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Three hundred and fifty three children with two or more unprovoked <z:hpo ids='HP_0001250'>seizures</z:hpo> were attended </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 238 entered a remission period and were proposed to stop medication, 216 accept </plain></SENT>
<SENT sid="6" pm="."><plain>Mean <z:hpo ids='HP_0001250'>seizure</z:hpo>-free time before medication withdrawal was 2.2 years </plain></SENT>
<SENT sid="7" pm="."><plain>Kaplan-Meier estimate of recurrence risk was 23% at 2 years (95% CI: 17-29) and 28% at 5 years (95% CI: 22-34) </plain></SENT>
<SENT sid="8" pm="."><plain>A remote symptomatic etiology, various <z:hpo ids='HP_0001250'>seizure</z:hpo> types and a history of prior <z:hpo ids='HP_0002373'>febrile seizures</z:hpo> or prior neonatal <z:hpo ids='HP_0001250'>seizures</z:hpo> were associated with a significant increase in recurrence risk in univariable and multivariable analyses using Cox proportional hazards model </plain></SENT>
<SENT sid="9" pm="."><plain>Recurrence risk at 2 years was 17% (95% CI: 11-23) for idiopathic/<z:e sem="disease" ids="C0086237" disease_type="Disease or Syndrome" abbrv="">cryptogenic epilepsies</z:e> and 41% (85% CI: 28-54) for remote symptomatic <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsies</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Recurrence risks at 2 years by <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> syndrome were <z:e sem="disease" ids="C0037769" disease_type="Disease or Syndrome" abbrv="">West syndrome</z:e> (0%), <z:e sem="disease" ids="C0376532" disease_type="Disease or Syndrome" abbrv="BECTS">benign rolandic epilepsy</z:e> (10%), <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> without unequivocal partial or <z:hpo ids='HP_0002197'>generalized seizures</z:hpo> (11%), benign infantile <z:hpo ids='HP_0001250'>seizures</z:hpo> (13%), <z:mp ids='MP_0003216'>absence epilepsy</z:mp> (16%), cryptogenic <z:e sem="disease" ids="C0014547" disease_type="Disease or Syndrome" abbrv="">partial epilepsies</z:e> (20%), symptomatic <z:e sem="disease" ids="C0014547" disease_type="Disease or Syndrome" abbrv="">partial epilepsies</z:e> (45%), <z:e sem="disease" ids="C0270854" disease_type="Disease or Syndrome" abbrv="">symptomatic generalized epilepsies</z:e> (54%) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Recurrence risk after withdrawal of <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> treatment in children is low </plain></SENT>
<SENT sid="12" pm="."><plain>Etiology and syndromic diagnosis are the main predictive factors </plain></SENT>
</text></document>